Literature DB >> 28569260

Association of left ventricular structural and functional abnormalities with aortic and brachial blood pressure variability in hypertensive patients: the SAFAR study.

C Chi1, S-K Yu1, R Auckle1, A A Argyris2,3, E Nasothimiou3, C Tountas2,3, E Aissopou2,3, J Blacher4, M E Safar4, P P Sfikakis2, Y Zhang1, A D Protogerou2,3.   

Abstract

Both brachial blood pressure (BP) level and its variability (BPV) significantly associate with left ventricular (LV) structure and function. Recent studies indicate that aortic BP is superior to brachial BP in the association with LV abnormalities. However, it remains unknown whether aortic BPV better associate with LV structural and functional abnormalities. We therefore aimed to investigate and compare aortic versus brachial BPV, in terms of the identification of LV abnormalities. Two hundred and three participants who underwent echocardiography were included in this study. Twenty-four-hour aortic and brachial ambulatory BP was measured simultaneously by a validated BP monitor (Mobil-O-Graph, Stolberg, Germany) and BPV was calculated with validated formulae. LV mass and LV diastolic dysfunction (LVDD) were evaluated by echocardiography. The prevalence of LV hypertrophy (LVH) and LVDD increased significantly with BPV indices (P⩽0.04) in trend tests. After adjustment to potential confounders, only aortic average real variability (ARV), but not brachial ARV or weighted s.d. (wSD, neither aortic nor brachial) significantly associated with LV mass index (P=0.02). Similar results were observed in logistic regression. After adjustment, only aortic ARV significantly associated with LVH (odds ratio (OR) and 95% confidence interval (CI): 2.28 (1.08, 4.82)). As for LVDD, neither the brachial nor the aortic 24-hour wSD, but the aortic and brachial ARV, associated with LVDD significantly, with OR=2.28 (95% CI: (1.03, 5.02)) and OR=2.36 (95% CI: (1.10, 5.05)), respectively. In summary, aortic BPV, especially aortic ARV, seems to be superior to brachial BPV in the association of LV structural and functional abnormalities.

Entities:  

Mesh:

Year:  2017        PMID: 28569260     DOI: 10.1038/jhh.2017.37

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  23 in total

1.  Association of left ventricular diastolic dysfunction with 24-h aortic ambulatory blood pressure: the SAFAR study.

Authors:  Y Zhang; G Kollias; A A Argyris; T G Papaioannou; C Tountas; G D Konstantonis; A Achimastos; J Blacher; M E Safar; P P Sfikakis; A D Protogerou
Journal:  J Hum Hypertens       Date:  2014-11-13       Impact factor: 3.012

2.  Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage: a LIFE substudy.

Authors:  Julie K K Vishram; Björn Dahlöf; Richard B Devereux; Hans Ibsen; Sverre E Kjeldsen; Lars H Lindholm; Giuseppe Mancia; Peter M Okin; Peter M Rothwell; Kristian Wachtell; Michael H Olsen
Journal:  J Hypertens       Date:  2015-12       Impact factor: 4.844

Review 3.  Recommendations for chamber quantification.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack Shanewise; Scott Solomon; Kirk T Spencer; Martin St John Sutton; William Stewart
Journal:  Eur J Echocardiogr       Date:  2006-02-02

4.  A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall.

Authors:  Grzegorz Bilo; Alessia Giglio; Katarzyna Styczkiewicz; Gianluca Caldara; Alberto Maronati; Kalina Kawecka-Jaszcz; Giuseppe Mancia; Gianfranco Parati
Journal:  J Hypertens       Date:  2007-10       Impact factor: 4.844

5.  A reliable index for the prognostic significance of blood pressure variability.

Authors:  Luis Mena; Salvador Pintos; Nestor V Queipo; José A Aizpúrua; Gladys Maestre; Tulio Sulbarán
Journal:  J Hypertens       Date:  2005-03       Impact factor: 4.844

Review 6.  Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis.

Authors:  Charalambos Vlachopoulos; Konstantinos Aznaouridis; Michael F O'Rourke; Michel E Safar; Katerina Baou; Christodoulos Stefanadis
Journal:  Eur Heart J       Date:  2010-03-02       Impact factor: 29.983

Review 7.  Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events.

Authors:  R B Devereux; M H Alderman
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

8.  Differences in the magnitude of wave reflection account for differential effects of amlodipine- versus atenolol-based regimens on central blood pressure: an Anglo-Scandinavian Cardiac Outcome Trial substudy.

Authors:  Charlotte H Manisty; Andrew Zambanini; Kim H Parker; Justin E Davies; Darrel P Francis; Jamil Mayet; Simon A McG Thom; Alun D Hughes
Journal:  Hypertension       Date:  2009-08-24       Impact factor: 10.190

9.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

Review 10.  Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis.

Authors:  Alastair J S Webb; Urs Fischer; Ziyah Mehta; Peter M Rothwell
Journal:  Lancet       Date:  2010-03-13       Impact factor: 79.321

View more
  5 in total

1.  The Impact of High Dietary Sodium Consumption on Blood Pressure Variability in Healthy, Young Adults.

Authors:  Kamila U Migdal; Matthew C Babcock; Austin T Robinson; Joseph C Watso; Megan M Wenner; Sean D Stocker; William B Farquhar
Journal:  Am J Hypertens       Date:  2020-04-29       Impact factor: 2.689

Review 2.  Blood pressure and its variability: classic and novel measurement techniques.

Authors:  Aletta E Schutte; Anastasios Kollias; George S Stergiou
Journal:  Nat Rev Cardiol       Date:  2022-04-19       Impact factor: 49.421

3.  Relation of blood pressure variability to left ventricular function and arterial stiffness in hypertensive patients.

Authors:  Sung-Hee Shin; Ji-Hoon Jang; Yong-Soo Baek; Sung-Woo Kwon; Sang-Don Park; Seong-Ill Woo; Dae-Hyeok Kim; Jun Kwan
Journal:  Singapore Med J       Date:  2019-03-11       Impact factor: 1.858

4.  Central blood pressure variability is increased in hypertensive patients with target organ damage.

Authors:  Alejandro de la Sierra; Julia Pareja; Sergi Yun; Eva Acosta; Francesco Aiello; Anna Oliveras; Susana Vázquez; Pedro Armario; Pedro Blanch; Cristina Sierra; Francesca Calero; Patricia Fernández-Llama
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-25       Impact factor: 3.738

5.  Arterial Stiffness Use for Early Monitoring of Cardiovascular Adverse Events due to Anthracycline Chemotherapy in Breast Cancer Patients. A Pilot Study.

Authors:  Cláudio Antônio de Souza; Ricardo Simões; Karina Braga Gomes Borges; Angélica Navarro de Oliveira; Juliana Barroso Zogeib; Bruno Alves; Marcus Vinicius Bolívar Malachias; Ana Paula Drummond-Lage; Bruno Almeida Rezende
Journal:  Arq Bras Cardiol       Date:  2018-09-21       Impact factor: 2.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.